IL-1β impairs Bmal1 expression and promoter activation in
diabetes [14] [15] [16] . Therefore, we next examined the impact of IL-1β exposure (and other pro- To confirm this we next assessed Bmal1 promoter activity using a stably- with mRNA expression studies, IL-1β (0.1-5 ng/ml) showed robust dose-dependent 1 9 2 suppression of Bmal1 promoter activation (up to 80%, Fig. 4b ) which corresponded with 1 9 3 decreased BMAL1 protein levels (Fig. 4c ). Bmal1 expression is regulated by opposing 1 9 4 8 diabetic, pre-diabetic, and T2DM individuals 38, 39 . Interestingly, Bmal1 mRNA expression 2 2 6 in human islets across the non-diabetic to prediabetic/T2DM range demonstrated a 2 2 7 positive correlation with the expression of transcripts functionally annotated to KEGG 2 2 8 pathways controlling circadian rhythms and β -cell function (e.g. circadian entrainment, 2 2 9 insulin secretion, metabolic pathways, etc., Fig. 5d-f ). In contrast, Bmal1 mRNA 2 3 0 expression in human islets was negatively correlated with KEGG pathways involved in 2 3 1 the regulation of β -cell failure, inflammation, and dedifferentiation (e.g. MAPK signaling, 2 3 2 NF-κB signaling, pathways in cancer etc., Fig. 5d-f ). This data provides first evidence of Recent reports demonstrate that the effects of cellular inflammatory stress may extend 2 3 9 to reprogramming of BMAL1:CLOCK genomic binding toward a distinct circadian 2 4 0 transcriptional program 29, 40, 41 . Therefore, we next set out to determine whether 2 4 1 exposure to IL-1β also alters genome-wide DNA binding patterns of BMAL1 and Interestingly, IL-1β treatment resulted in an overall increase in total binding sites for 2 4 6 BMAL1 (~18% increase), CLOCK (27%) and BMAL1:CLOCK cobound (27%), indicative 2 4 7 of a wider distribution of BMAL1 and CLOCK binding in β -cells during IL-1β-mediated 2 4 8 inflammation ( Fig. 6c and Supplementary Fig. 8 ). First, to test whether IL-1β leads to 2 4 9 relocalization of BMAL1/CLOCK binding from sites annotated to genes regulating 2 5 0 circadian rhythms, we performed gene-set enrichment analysis (GSEA) of annotated 2 5 1 target genes in vehicle and IL1-β conditions (unique plus common) using GO biological vehicle and IL-1β conditions (Fig. 6d , [FDR] q = 0.00), implying that IL-1β doesn't alter 2 5 5 BMAL1/CLOCK genome-wide binding to core circadian clock genes in β -cells. Secondly, we performed functional pathway analysis (GO and KEGG) on a unique 2 5 7 subset of 301 (BMAL1), 1323 (CLOCK), and 282 (BMAL1:CLOCK cobound) binding 2 5 8 sites exclusive to the IL-1β treatment conditions ( Fig. 6e ). Importantly, this analysis 2 5 9 revealed that exposure to IL-1β results in the enrichment of BMAL1 and CLOCK binding 2 6 0 sites in the proximity of genes functionally annotated to pathways regulating β -cell 2 6 1 apoptosis, inflammation, and dedifferentiation (e.g. mitophagy, FOXO signaling, MAPK 2 6 2 signaling etc.) ( Fig. 6e ). This data suggests that under pro-inflammatory conditions Our study shows that IL-1β disrupts β -cell circadian clock in part through 3 0 7
interfering with the expression of key circadian transcription factor Bmal1. Indeed,
Bmal1 is the only non-redundant clock gene indispensable for the regulation of transcriptional repressor REV-ERBα. This is consistent with work that has identified an of T1DM and T2DM 36, 37 . Finally, our work also suggests that IL-1β may control β -cell
Bmal1 expression by regulating expression of its transcriptional repressor, REV-ERBα. Current data also suggests that the effects of inflammation on the β -cell circadian 3 2 6 clock may extend beyond suppression of core circadian clock genes, but also program as recently demonstrated in lung and liver cells exposed to pro-inflammatory 3 2 9 conditions such as endotoxemia, LPS, and high fat diet 29, 40, 41 . For example, lung 3 3 0 endotoxemia led to an emergence of circadian rhythms in genes enriched for key pro- chromatin accessibility, providing a plausible explanation for the emergence of presence of a robust circadian transcriptional program in isolated human islets that is 3 5 1 dependent on core circadian clock gene expression 16, 52 . Stamenkovic and colleagues 3 5 2 previously reported that isolated human islets from T2DM patients exhibit a significant 3 5 3 decrease in the expression of core circadian clock genes PER1, PER2, and CRY2, but One potential reason for the discrepancy between the findings by Stamenkovic et al. Our data provides the evidence that the development of hyperglycemia in insulin secretion in diabetes-prone populations 54,55 . Importantly, these effects are likely 3 6 8 due to increased islet exposure to pro-inflammatory cytokines, rather than exposure to 3 6 9 hyperglycemia per se, since culture of islets in hyperglycemic conditions alone fails to 3 7 0 alter circadian clock function 9 . Moreover, potential IL-1β-mediated addition of novel to treat metabolic disorders such as diabetes mellitus. Institutional Animal Care Committee. IFNγ for 24 hours. Cells were washed in 1X PBS and 1X cell lysis buffer was added. Plates were put on an orbital shaker for 20 minutes, and cells lysates were collected, with SYBR Green Master Mix (ABI) with gene-specific primers ( Supplementary Table 1 )
for a total reaction volume of 25 µl. qRT-PCR analysis was performed using the ABI Membranes were blocked in 5% milk (BioRad) and incubated with antibodies for BMAL- with 1% formaldehyde for 10 min, followed by quenching with 125 mM glycine for 5 min 4 6 4 at room temperature. Fixed cells were washed with TBS and the cell pellets were frozen 4 6 5 at -80°C. ChIP-seq was performed as previously described 59 . Briefly, cells were prewashed protein G-agarose beads, the reactions were further incubated for 3 hours. The beads were extensively washed with ChIP buffer, high salt buffer, LiCl 2 buffer, and 4 7 7 TE buffer. Bound chromatins were eluted and reverse-crosslinked at 65°C overnight. Encyclopedia of Genes and Genomes) pathways of identified gene targets. Clinic autopsy archives with approval from the Institutional Research Biosafety Board. Paraffin-embedded pancreatic sections were immunostained for Insulin (ab7842; Health, Bethesda, MD) was used to quantify BMAL1 and RORα expression by Services, Anglesey, UK). All data was presented as means ± SEM and assumed 5 0 8 statistically significant at p<.05. 110, 251-260 (2002) . Humans. Endocrinology 158, 1074-1084 (2017) . in Rats. Diabetes 62, 3469-3478 (2013) . Sci U S A 112, E2225-2234 (2015) . 
